BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/6/2017 1:27:00 PM | Browse: 715 | Download: 1454
 |
Received |
|
2016-10-21 10:49 |
|
Peer-Review Started |
|
2016-10-24 08:48 |
|
To Make the First Decision |
|
2016-12-28 17:26 |
|
Return for Revision |
|
2017-01-03 14:53 |
|
Revised |
|
2017-01-12 07:14 |
|
Second Decision |
|
2017-02-06 14:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2017-02-08 09:52 |
|
Articles in Press |
|
2017-02-08 09:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-02-22 17:59 |
|
Publish the Manuscript Online |
|
2017-03-06 13:24 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jacob A Langness, Matthew Nguyen, Amanda Wieland, Gregory T Everson and Jennifer J Kiser |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jennifer J Kiser, PhD, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Mail Stop C238, 12850 E. Montview Blvd. V20-4102 , Aurora, CO 80045, United States. jennifer.kiser@ucdenver.edu |
| Key Words |
Clinical pharmacist; Drug-drug interaction; Hepatitis C virus treatment |
| Core Tip |
Identification and management of potential drug-drug interactions (DDI) is a critical aspect of current hepatitis C virus (HCV) treatment. This retrospective analysis of patients prescribed common HCV treatments identifies DDIs and the interventions made by the clinical pharmacist, as well as the approximate time required to complete these activities. This novel review illustrates that DDIs are common in this population. Identification and management of DDIs is resource intensive and requires medication adjustments and increased monitoring. An interdisciplinary care team including a clinical pharmacist is critical to optimize patient care for new HCV therapies. |
| Publish Date |
2017-03-06 13:24 |
| Citation |
Langness JA, Nguyen M, Wieland A, Everson GT, Kiser JJ. Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions. World J Gastroenterol 2017; 23(9): 1618-1626 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i9/1618.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i9.1618 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
